Comparing the Diagnostic Performance of Integrated 18F-FDG PET-MRI and MRI for the Identification of Local Recurrences of Soft Tissue Sarcomas

Authors

Youssef Erfanian1,*, Johannes Gruneisen1, Lars Podleska1, Torsten Poeppe1, Lale Umutlu1
1University Hospital Essen, Germany
*Corresponding Author: University Hospital Essen, Germany, Youssef.Erfanian@uk-essen.de. Email: Youssef.Erfanian@uk-essen.de

Iranian Journal of Radiology:Vol. 14, issue Special Issue; e47962
Published online:Apr 12, 2017
Article type:Abstract
Received:Dec 20, 2016
Accepted:Feb 07, 2017
How to Cite:Erfanian Y, Gruneisen J, Podleska L, Poeppe T, Umutlu L. Comparing the Diagnostic Performance of Integrated 18F-FDG PET-MRI and MRI for the Identification of Local Recurrences of Soft Tissue Sarcomas. I J Radiol. 2017;14(Special Issue):e47962. doi: https://doi.org/10.5812/iranjradiol.47962

Abstract

Objectives:

To assess the diagnostic accuracy of PET-MRI and MRI alone for the detection of local recurrences of soft tissue sarcomas (STS) after initial surgical resection of the primary tumors.

Methods:

A total of 41 patients with a clinically suspected tumor relapse of STS underwent an 18F-FDG- PET-MRI examination for assessment of local recurrence. Two experienced physicians interpreted the MRI data and subsequently the PET-MRI datasets in two separate reading sessions and were instructed to identify potential local tumor recurrences. Additionally, the diagnostic confidence in each reading for the identification of malignant lesions was determined. A McNemar test was applied to test for differences of both ratings and a Wilcoxon signed-rank test was used to identify differences of the confidence levels. Histopathological verification as well as follow-up imaging was applied as the standard of reference.

Results:

A tumor relapse was present in 27 / 41 patients. Calculated sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accurary for the detection of local tumor recurrence was 81%, 85%, 91%, 70%, 82% for MRI and 96%, 75%, 89%, 91%, 90% for PET-MRI (P > 0.05). Furthermore, PET/MRI showed significantly higher confidence levels (P < 0.05) for the determination of malignant lesions.

Conclusions:

Our results demonstrate 18F-FDG PET-MRI to be an excellent imaging method in the evaluation of recurrent STS after surgical excision, as it displays superior detection accuracy as compared to routine MRI follow-up examinations.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2017, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

12
Apr
2017
The Role of 18F FDG PET/CT in Clinical Management of Breast Cancer; Additional Value Over Conventional Imaging Modalities

The Role of 18F FDG PET/CT in Clinical Management of Breast Cancer; Additional Value Over Conventional Imaging Modalities

Mehrdad Bakhshayeshkaram,
Farahnaz Aghahosseini,
Abtin Doroudinia

Bakhshayeshkaram M, Aghahosseini F, Doroudinia A. The Role of 18F FDG PET/CT in Clinical Management of Breast Cancer; Additional Value Over Conventional Imaging Modalities. I J Radiol. 2017;14(Special Issue):e47975. doi: https://doi.org/10.5812/iranjradiol.47975

20
Jun
2016
Pattern of Recurrence of Myxofibrosarcoma is not Associated with Pattern at Presentation or Rate of Delayed Diagnosis

Pattern of Recurrence of Myxofibrosarcoma is not Associated with Pattern at Presentation or Rate of Delayed Diagnosis

Corey Daniels,
Wei-Lien Wang,
John Edward Madewell,
Wei Wei,
Behrang Amini

Daniels C, Wang W, Madewell JE, Wei W, Amini B. Pattern of Recurrence of Myxofibrosarcoma is not Associated with Pattern at Presentation or Rate of Delayed Diagnosis. I J Radiol. 2017;14(1):e13469. doi: https://doi.org/10.5812/iranjradiol.32548

1
Dec
2018
Impact of FDG-PET and Dynamic Contrast-Enhanced MRI in Comparison with DWI for N-Staging in Lung Cancer Patients

Impact of FDG-PET and Dynamic Contrast-Enhanced MRI in Comparison with DWI for N-Staging in Lung Cancer Patients

Paul Flechsig,
Heike Zabeck,
Sebastian Reubold,
Christos Sachpekidis,
Hendrik Rathke,
Manuel R&amp;ouml;hrich
,et al.

Flechsig P, Zabeck H, Reubold S, Sachpekidis C, Rathke H, et al. Impact of FDG-PET and Dynamic Contrast-Enhanced MRI in Comparison with DWI for N-Staging in Lung Cancer Patients. I J Radiol. 2019;16(1):e68638. doi: https://doi.org/10.5812/iranjradiol.68638

30
Mar
2013
The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

M Abedi,
D Farrokh,
Fatemeh Homaei Shandiz,
A Joulaee,
R Anbiaee,
B Zandi
,et al.

Abedi M, Farrokh D, Homaei Shandiz F, Joulaee A, Anbiaee R, et al. The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. Int J Cancer Manag. 2013;6(1):e80382. doi:

10
Jan
2016
Role of 18F-fluorodeoxyglucose  Positron Emission Tomography/Computed Tomography  in the Evaluation of Cytologically Indeterminate Thyroid Nodules

Role of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Cytologically Indeterminate Thyroid Nodules

Gulgun Buyukdereli,
Yasemin Aktar,
Ertan Kara,
Aysun Uguz,
Husnu Sonmez

Buyukdereli G, Aktar Y, Kara E, Uguz A, Sonmez H. Role of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Cytologically Indeterminate Thyroid Nodules. I J Radiol. 2016;13(1):e21186. doi: https://doi.org/10.5812/iranjradiol.21186

More by these authors

Youssef ErfanianPubMedScholar
Johannes GruneisenPubMedScholar
Lars PodleskaPubMedScholar
Torsten PoeppePubMedScholar
Lale UmutluPubMedScholar
Share
Cited by
Metrics